Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus

British Journal of Dermatology

Volumn 141, Issue 4, 1999, Pages 739-746

  Reich, K ^a   Brinck, U ^a   Letschert, M ^a   Blaschke, V ^a   Dames, K ^a   Braess, J ^a   Wormann B ^a   Runger T M ^a   Neumann, C ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Anti desmosomal antibodies; Apoptosis; Autoimmune disease; Cytotoxic T lymphocytes; Fas fas ligand pathway; Paraneoplastic pemphigus

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AUTOANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUDARABINE PHOSPHATE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CELL DEATH; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INTRAVENOUS DRUG ADMINISTRATION; KERATINOCYTE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PRIORITY JOURNAL;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; DRUG ERUPTIONS; EPIDERMIS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; IN SITU NICK-END LABELING; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOMA, NON-HODGKIN; PEMPHIGUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIDARABINE;

EID: 0032692296     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.03123.x     Document Type: Article

References (34)

1. 1 Anhalt GJ. Kim SC, Stanley JR et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-35.
2. 2 Rybojad M, Leblanc T, Flageul B et al. Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma. Br J Dermatol 1993; 128: 418-22.
3. 3 Lemon MA, Weston WL, Huff JC. Childhood paraneoplastic pemphigus associated with Castleman's tumour. Br J Dermatol 1997; 136: 115-17.
4. 4 Hashimoto T, Amagai M, Watanabe K et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995; 104: 829-34.
5. 5 Joly P, Thomine E, Gilbert D et al. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. J Invest Dermatol 1994; 103: 65-72.
6. 6 Izaki S. Yoshizawa Y, Hashimoto T et al. Paraneoplastie pemphigus: report of a case. J Dermatol 1996; 23: 397-404.
7. 7 Mehregan DR, Oursler JR, Leiferman KM et al. Paraneoplastic pemphigus: a subset of patients with pemphigus and neoplasia. J Cutan Pathol 1993; 20: 203-10.
8. 8 Zillikens D, Bröcker EB. Paraneoplastischer Pemphigus. Induktion von Autoantikörpern gegen Strukturproteine der Haut. Hautarzt 1994; 45: 827-33.
9. 9 Zaki I, Parker I, Allen BR. Graft versus host disease due to a lymphoma. Br J Dermatol 1996; 135(47): 61 (Abstr).
10. 10 Liu AY, Valenzuela R, Helm TN et al. Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol 1993; 28: 696-9.
11. 11 Meier F, Sönnichsen K, Schaumburg-Lever G et al. Epidermolysis bullosa acquisita: Efficacy of high-dose intravenous immunoglobulins. J Am Acad Dermatol 1993; 29: 334-7.
12. 12 Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
13. 13 Paul C, Wolkenstein P, Adle H et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996; 134: 710-14.
14. 14 Englert R, Harwix S, Reich K et al. T cell clones from lesional skin of cutaneous T-cell-lymphoma express functional CD95. J Invest Dermatol 1998; 110: 525 (Abstr).
15. 15 Goodman E, Fiedor P, Fein S et al. Fludarabine phosphate: a DNA synthesis inhibitor with potent immunosuppressive activity and minimal clinical toxicity. Am Surg 1996; 62: 435-42.
16. 16 Di Raimondo F. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymph 1993; 11: 63-8.
17. 17 Maung ZT, Wood AC, Jackson GH et al. Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukemia. Br J Haematol 1994; 88: 649-52.
18. 18 Briz M, Cabrera R, Sanjuán I et al. Diagnosis of transfusion-associated graft-versus-host disease by polymerase chain reaction in fludarabine-treated B-chronic lyrnphocytic leukaemia. Br J Haematol 1995; 91: 409-11.
19. 19 Scully R, Mark E, McNeely M, McNeely B. Case records of the Massachusetts General Hospital: case 19-1992. N Engl J Med 1992; 326: 1276-84.
20. 20 Bazarbachi A, Bachelez H, Dehen L et al. Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine. (Letter). Ann Oncol 1995; 6: 730-1.
21. 21 Horn TD, Analt GJ. Histologic features of paraneoplastic pemphigus. Arch Dermatol 1992; 128: 1091-5.
22. 22 Stevens SR, Griffiths CEM, Anhalt GJ, Cooper KD. Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption. Arch Dermatol 1993; 129: 866-9.
23. 23 Camisa C, Helm TN. Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol 1993; 129: 883-5.
24. 24 Volc-Platzer B, Hönigsmann H, Hinterberger W, Wolff K. Photochemotherapy improves chronic cutaneous graft-versus-host disease. J Am Acad Dermatol 1990; 23: 220-8.
25. 25 Baker MB, Altmann NH, Podack ER, Levy RB. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med 1996; 183: 2645-56.
26. 26 Gilliam AC, Whitaker-Menezes D, Korngold R, Murphy GF. Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease. J Invest Dermatol 1996; 107: 377-83.
27. 27 Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-56.
28. 28 Berke G. The CTL's kiss of death. Cell 1995; 81: 9-12.
29. 29 Correia O, Delgado L, Ramos JP et al. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Arch Dermatol 1993; 129: 466-8.
30. 30 Paquet P, Nikkels A, Arrese JE et al. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol 1994; 130: 605-8.
31. 31 Sayama Y, Konehara S. Watanabe Y, Miki Y. Expression of FAS antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocyles. J Invest Dermatol 1994; 103: 330-4.
32. 32 Matsue H, Kobayashi H, Hosokawa T et al. Keratinocytes constitutively express the FAS antigen that mediates apoptosis in IFNγ-treated cultured keratinocytes. Arch Dermatol Res 1995; 287: 315-20.
33. 33 Bennion SD, Middleton MH, David-Bajar KM et al. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease. J Invest Dermatol 1995; 105: 71-98.
34. 34 Abreu-Martin MT, Vidrich A, Lynch DH, Targan SR. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J Immunol 1995; 155: 4147-54.